Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

4.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.2K
Skin Cancer01:30

Skin Cancer

6.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.7K
Pigmentation01:19

Pigmentation

5.1K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
5.1K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

3.3K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.3K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

684
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
684
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

When Antibiotics Leave a Mark: Minocycline-Induced Hyperpigmentation.

Clinical case reports·2026
Same author

Waiting for Access: How Bureaucracy Blocks Innovation in Australian Dermatology.

The Australasian journal of dermatology·2025
Same author

Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies.

The Australasian journal of dermatology·2025
Same author

Is the Future Oral? Towards Sustainable and Patient-Centered Biologic Treatment in Dermatology.

The Australasian journal of dermatology·2025
Same author

Social Media and the Re-Emergence of Dangerous Tanning Practices.

The Australasian journal of dermatology·2025
Same journal

Contact Allergens Relevant to LGBTQI Populations: A Narrative Review and Practical Considerations.

The Australasian journal of dermatology·2026
Same journal

A Retrospective Review of Scabies Cases Managed by the Dermatology Department in a North Queensland Hospital Over a 10-Month Period.

The Australasian journal of dermatology·2026
Same journal

Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.

The Australasian journal of dermatology·2026
Same journal

Allergic Contact Dermatitis Caused by Online-Purchased Black Henna Temporary Tattoos.

The Australasian journal of dermatology·2026
Same journal

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026
Same journal

Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era.

The Australasian journal of dermatology·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.6K

Vitiligo treatment update.

Benjamin S Daniel1, Richard Wittal

  • 1University of New South Wales, Sydney, New South Wales, Australia.

The Australasian Journal of Dermatology
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

This review examines common vitiligo treatments, assessing their effectiveness in repigmentation for this widespread depigmenting skin condition. Evidence for various therapies is analyzed to understand their success rates.

Keywords:
managementtreatmentvitiligo

More Related Videos

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

2.2K
Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.2K

Related Experiment Videos

Last Updated: Apr 19, 2026

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.6K
Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

2.2K
Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

12.2K

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Vitiligo is a prevalent depigmenting disorder affecting skin and mucous membranes.
  • Current treatment strategies for vitiligo yield variable repigmentation outcomes.

Purpose of the Study:

  • To review the evidence supporting commonly utilized therapies for vitiligo.
  • To evaluate the efficacy of different treatment modalities in achieving repigmentation.

Main Methods:

  • Systematic review of existing literature on vitiligo treatments.
  • Analysis of studies reporting repigmentation rates for various therapeutic interventions.

Main Results:

  • The review synthesizes data on the effectiveness of established and emerging vitiligo therapies.
  • Variability in repigmentation success is noted across different treatment approaches.

Conclusions:

  • Evidence supports the use of several therapies for vitiligo, though outcomes differ.
  • Further research may optimize treatment protocols for vitiligo patients.